Get the Stockscreener App
1.63
5.16%
0.08
After Hours:
1.63
Calidi Biotherapeutics Inc stock is traded at $1.63, with a volume of 189.64K.
It is up +5.16% in the last 24 hours and up +0.62% over the past month.
Calidi Biotherapeutics Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. It engages in advancing a potent allogeneic stem cell capable of carrying an anti-tumor payload for use in multiple oncology indications, including high-grade gliomas and solid tumors. The company's cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Its pipeline of products candidates in the clinic includes NeuroNova that are allogeneic neural stem cells loaded with an oncolytic adenovirus for the treatment of high-grade gliomas; and SuperNova, which are allogeneic adipose-derived mesenchymal stem cells loaded with tumor-selective CAL1 oncolytic vaccinia virus for the treatment of advanced metastatic solid tumors. The company was founded in 2014 and is headquartered in San Diego, California.
See More
Previous Close:
$1.55
Open:
$1.55
24h Volume:
189.64K
Relative Volume:
0.36
Market Cap:
$8.29M
Revenue:
-
Net Income/Loss:
$-23.36M
P/E Ratio:
-2.2123
EPS:
-0.7368
Net Cash Flow:
-
1W Performance:
+4.49%
1M Performance:
+0.62%
6M Performance:
-69.13%
1Y Performance:
-87.19%
1-Day Range:
$1.53
$1.63
1-Week Range:
$1.51
$1.68
52-Week Range:
$1.41
$46.68
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
Name
Calidi Biotherapeutics Inc
Sector
Industry
Phone
(858) 794-9600
Address
4475 Executive Drive, Suite 200, San Diego
Compare CLDI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLDI
Calidi Biotherapeutics Inc
|
1.63 | 8.29M | 0 | -23.36M | 0 | -0.7368 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-22-23 | Initiated | H.C. Wainwright | Buy |
| Oct-09-23 | Initiated | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc Stock (CLDI) Latest News
Will Calidi Biotherapeutics Inc. stock keep outperforming rivalsWeekly Loss Report & Weekly High Return Forecasts - newser.com
Will Calidi Biotherapeutics Inc. rebound enough to break evenTrade Entry Summary & Advanced Swing Trade Entry Plans - newser.com
Full technical analysis of Calidi Biotherapeutics Inc. stockJuly 2025 Spike Watch & Long-Term Investment Growth Plans - newser.com
Can a trend reversal in Calidi Biotherapeutics Inc. lead to recoveryTrade Risk Summary & Free Growth Oriented Trading Recommendations - newser.com
Is Calidi Biotherapeutics Inc. forming a reversal patternPortfolio Update Report & Expert Approved Momentum Trade Ideas - newser.com
Is Calidi Biotherapeutics Inc. stock supported by strong cash flowsEarnings Overview Summary & AI Powered Market Entry Ideas - newser.com
How to manage a losing position in Calidi Biotherapeutics Inc.Long Setup & Weekly Setup with ROI Potential - newser.com
News impact scoring models applied to Calidi Biotherapeutics Inc.Quarterly Performance Summary & High Accuracy Swing Entry Alerts - newser.com
How institutional ownership impacts Calidi Biotherapeutics Inc. stockProfit Target & Daily Oversold Bounce Ideas - newser.com
Is Calidi Biotherapeutics Inc. stock bottoming outJuly 2025 News Drivers & Consistent Growth Stock Picks - newser.com
What’s the recovery path for long term holders of Calidi Biotherapeutics Inc.2025 Key Highlights & AI Enhanced Trading Signals - newser.com
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Pueblo Chieftain
How Calidi Biotherapeutics Inc. stock reacts to monetary easingGold Moves & Weekly Chart Analysis and Guides - newser.com
Applying big data sentiment scoring on Calidi Biotherapeutics Inc.2025 Price Targets & Weekly High Return Opportunities - newser.com
Can technical indicators confirm Calidi Biotherapeutics Inc.’s reversalPortfolio Performance Summary & Free Fast Gain Swing Trade Alerts - newser.com
Published on: 2025-10-10 04:53:50 - newser.com
How rising interest rates impact Calidi Biotherapeutics Inc. stockTrade Ideas & Weekly Breakout Opportunity Watchlist - newser.com
Will Calidi Biotherapeutics Inc. stock maintain growth storyQuarterly Market Summary & AI Enhanced Execution Alerts - newser.com
Published on: 2025-10-09 06:45:08 - newser.com
Will Calidi Biotherapeutics Inc. stock justify high valuationMarket Weekly Review & Weekly Top Stock Performers List - newser.com
Analyzing Calidi Biotherapeutics Inc. with risk reward ratio chartsJuly 2025 Intraday Action & Free AI Powered Buy and Sell Recommendations - newser.com
Why ETFs are accumulating Calidi Biotherapeutics Inc. stockIPO Watch & Low Drawdown Investment Strategies - newser.com
Will Calidi Biotherapeutics Inc. continue its uptrendWeekly Market Report & Low Risk Entry Point Guides - newser.com
Is it time to cut losses on Calidi Biotherapeutics Inc.Take Profit & Precise Swing Trade Entry Alerts - newser.com
Visual analytics tools that track Calidi Biotherapeutics Inc. performanceQuarterly Market Review & Community Consensus Trade Signals - newser.com
Using Ichimoku Cloud for Calidi Biotherapeutics Inc. technicalsAnalyst Upgrade & Low Drawdown Trading Strategies - newser.com
Calidi Biotherapeutics Inc Stock (CLDI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Cap:
|
Volume (24h):